tbuckley/cabot-search huggingface dataset:
Surgeon General's Workshop on Health Promotion and Aging: Summary Recommendations of Physical Fitness and Exercise Working Group
Journal: JAMA (1989)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
UNIFORM LEGISLATION OR RECIPROCITY.
Journal: JAMA (1900)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
TROPICAL ANEMIA (ANKYLOSTOMIASIS) IN PORTO RICO.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Nonalcoholic Steatohepatitis
Authors: Michael Kirsch
Journal: Annals of Internal Medicine (1997)

Letters1 September 1997Nonalcoholic SteatohepatitisMichael Kirsch, MDMichael Kirsch, MDHighland Heights, OH 44143Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-127-5-199709010-00018 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:In Sheth and colleagues' review of NASH [1], the authors advocate extensive evaluation of patients with unexplained elevations in liver enzyme levels. After a history and, presumably, a physical examination, specific recommendations include viral hepatitis serologic testing; iron studies; measurement of ceruloplasmin levels, α-antitrypsin levels and phenotype, and anti-mitochondrial and antinuclear antibodies; liver ultrasonography; and Doppler assessment of hepatoportal vasculature. The authors advise that “if none of the above tests are definitive, then a liver biopsy is recommended to confirm or rule out NASH … .”I believe that their diagnostic approach is excessive. Do the authors ...References1. Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med. 1997; 126:137-45. Google Scholar Author, Article, and Disclosure InformationAffiliations: Highland Heights, OH 44143 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByStrategisches Management und Strategiegenese 1 September 1997Volume 127, Issue 5Page: 411KeywordsBiopsyEnzymesHematologic testsHepatitis ALiverLiver diseasesNonalcoholic steatohepatitisPatient advocacyPhenotypesUltrasound imaging Issue Published: 1 September 1997 CopyrightCopyright © 1997 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...
Books
Journal: Allergy (1990)

Book reviewed in this article: Hoiby, N., Stenvang Pedersen, S., Shand, G. H., Döring, G. &amp; Holder, I. A. (eds.): Pseudomonas aeruginosa infection Shakib, F. (ed.): Autoantibodies to immunoglobulins Lemmer, B. (ed.): Chronopharmacology: cellular and biochemical interactions (Cellular Clocks Series/3)
A Comparison on the Emission of Polycyclic Aromatic Hydrocarbons and Their Corresponding Carcinogenic Potencies from a Vehicle Engine Using Leaded and Lead-Free Gasoline
Authors: Hsiao-Hsuan Mi, Wen-Jhy Lee, Perng-Jy Tsai, Chung-Ban Chen
Journal: Environmental Health Perspectives (2001)

Our objective in this study was to assess the effect of using two kinds of lead-free gasoline [including 92-lead-free gasoline (92-LFG) and 95-lead-free gasoline (95-LFG), rated according to their octane levels] to replace the use of premium leaded gasoline (PLG) on the emissions of polycyclic aromatic hydrocarbons (PAHs) and their corresponding benzo[a]pyrene equivalent (BaP(eq)) amounts from the gasoline-powered engine. The results show that the three gasoline fuels originally contained similar total PAHs and total BaP(eq) contents; however, we found significant differences in the engine exhausts in both contents. The above results suggest that PAHs originally contained in the gasoline fuel did not affect the PAH emissions in the engine exhausts. The emission factors of both total PAHs and total BaP(eq) obtained from the three gasoline fuels shared the same trend: 95-LFG > PLG > 92-LFG. The above result suggests that when PLG was replaced by 95-LFG, the emissions would increase in both total PAHs and total BaP(eq), but when replaced by 92-LFG would lead to the decreased emissions of both contents. By taking emission factors and their corresponding annual gasoline consumption rates into account, we found that both total PAH and total BaP(eq) emissions increased from 1994 to 1999. However, the annual increasing rates in total BaP(eq) emissions were slightly higher than the corresponding increasing rates in total PAHs.
CPAP and Low Oxygen Saturation for Very Preterm Babies?
Authors: Bruno Vincenzi, Sankhala Kk, Pandya Dm, Soefje Sa
Journal: New England Journal of Medicine (2010)

corrections of 125 mg and 80 mg.Weekly follow-up visits with each patient showed that pruritus was prevented in both patients (score on the visual-analogue scale, 0 in one patient and 1 in the other).After 2 months of treatment with erlotinib as well as aprepitant prophylaxis, no further episodes of severe pruritus were recorded (though the rash remained present).Both patients now are waiting for tumor response to be assessed.It is not yet clear whether aprepitant influences antitumor responses.Further clinical data are necessary to confirm our conclusion that aprepitant may be useful to treat and prevent pruritus in patients with cancer who are receiving erlotinib.
Clinical Studies in Epilepsy. From the Craig Colony for Epileptics at Sonyea, New York
Journal: JAMA (1900)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Ophthalmic examination in diabetes mellitus
Authors: S. P. Griffith
Journal: JAMA (1994)

<h3>To the Editor.</h3> —Dr Brechner and colleagues<sup>1</sup>point out in their recent article that "about half of adults with diabetes in the United States are not receiving timely and recommended eye care to detect and treat retinopathy." Screening for retinopathy can identify early disease and prevent major vision loss. However, we have still not determined the most cost-effective screening method. Numerous articles have been published evaluating the accuracy and cost-effectiveness of various strategies of screening for diabetic retinopathy. Most have defined "accuracy" as diagnosing specific grades of diabetic retinopathy. For example, Singer et al<sup>2</sup>reviewed a previous study by Moss et al<sup>3</sup>and calculated that ophthalmoscopy had a sensitivity of 79% and a specificity of 99% for the detection of proliferative retinopathy. Of the patients known to have proliferative retinopathy by the criterion standard examination in the study by Moss et al,<sup>3</sup>screening identified proliferative retinopathy
Multiple nodules of the small bowel
Authors: B. J. Haskin
Journal: JAMA (1967)

Dr. Bruce J. Haskin: This is the third Massachusetts General Hospital admission of a 45-year-old white man who was admitted because of gastrointestinal bleeding. For one month he had noted progressive fatigue, weakness, pallor, and light-headedness. The hematocrit reading was 27 and the guaiac test on the stool was strongly positive. <h3>Discussion</h3> Dr. Stanley M. Wyman: What is your opinion of this case, Dr. Bohrer? Dr. Stanley P. Bohrer: There is an obvious rounded defect in the fourth portion of the duodenum (Fig 1). The mucosal pattern adjacent to it looks fairly normal and is probably intact. I see nothing which suggests stretching or erosion of the mucosa. I am trying to decide whether it is an extramucosal defect or an intraluminal mass. I think I would favor the latter. There are some areas farther down in the bowel (Fig 2) which have a somewhat similar appearance, but I would
American Journal of Ophthalmology, Chicago
Journal: JAMA (1970)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Med Res Engineering, Garden City, NY
Journal: JAMA (1967)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Editorial Board
Authors: Bruce Thiers, Dirk Elston, Detra Davis, Anna Krueger, Kenneth Katz, Jack Lesher, Mary Spellman, Jeffrey Weinberg, Dermatologic Surgery, Clifford Perlis, Julie Prendiville, Frcpc Dermatopathology, John Maize, Social Media, Emily Altman, Robert Dellavalle, J Smith, Editors Emeritus, Richard Dobson, Jeffrey Bernhard, Calvin Mccall, Brett Sloan, James Solomon, Stephen Tyring, George Hruza, Pediatric Dermatology, Kelly Cordoro, Dermatopathology Carlson, Tammie Ferringer, Cyberdermatology Consultant, Daniel Siegel, Clara Kim, Bryan Anderson, Salvador Arias-Santiago, Trisha Beute, John Binhlam, Diana Bolotin, Markus Braun-Falco, Nooshin Brinster, Patrick Carrington, Zoe Draelos, Nananamibia Duffy, Laura Ferris, David Fivenson, Joel Gelfand, Camille Introcaso, Nathaniel Jellinek, Jonathan Kantor, Matthew Kanzler, Kevin Kia, Nikki Levin, Kenneth Linden, Jason Lott, Omar Lupi, J Am, Acad Dermatol
Journal: Journal of the American Academy of Dermatology (2015)
Journal of Immunology, Baltimore
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Overview of Human Health and Chemical Mixtures: Problems Facing Developing Countries
Authors: Leticia Yáñez, Deogracias Ortiz, Jaqueline Calderón, Lilia Batres, Leticia Carrizales, Jesús Mejía, Lourdes Martínez, Edelmira García-Nieto, Fernando Díaz-Barriga
Journal: Environmental Health Perspectives (2002)
Suppression of Alveolar Macrophage Membrane Receptor-Mediated Phagocytosis by Model and Actual Particle-Adsorbate Complexes. Initial Contact with the Alveolar Macrophage Membrane
Authors: George J. Jakab, Terence H. Risby, Shelley S. Sehnert, Robert R. Hmieleski, Jane E. Farrington
Journal: Environmental Health Perspectives (1990)

Alveolar macrophages were treated with carbon blacks and adsorbates in order to evaluate the biologic effect of adsorbate, adsorbent and adsorbate-adsorbent complexes. Their capacity to phagocytize a subsequent challenge via the Fc-membrane receptor was quantified. Phagocytosis was suppressed in a dose-related manner with increasing concentrations of both carbon blacks and adsorbates. Carbon black N339 covered with 0.5 monolayers of the adsorbates suppressed phagocytosis more than N339 without the adsorbates. Increasing the adsorbate acrolein coverage from 0.5 to greater than 2.0 monolayers suppressed phagocytosis in a dose-related manner. Finally, samples of diesel particulate matter collected from an engine operated on a pure hydrocarbon fuel with various oxidizers, air (PSU #1) and an oxidizer free of nitrogen (N-free) were tested. Treatment of the macrophages with PSU #1 had a negligible effect on phagocytosis whereas the N-free sample suppressed phagocytosis in a dose-related manner. The data show that alveolar macrophage Fc-receptor-mediated phagocytosis is affected by: carbon black and adsorbate identity and concentration, coverage of the carbon black with adsorbates, and the oxidizer used in the generation of particles emitted by a diesel engine.
Access to care for poor children. Separate and unequal?
Authors: R. F. St Peter
Journal: JAMA (1992)

<h3>Objective.</h3> —To determine how coverage by Medicaid affects the use of preventive care, as well as the location and continuity of care for poor children. <h3>Design.</h3> —Analysis of the 1988 National Health Interview Survey on Child Health. <h3>Setting.</h3> —Nationally representative sample of the US noninstitutionalized, civilian population. <h3>Participants.</h3> —A total of 17710 children under 18 years of age selected in a stratified cluster sampling of US households. <h3>Intervention.</h3> —None. <h3>Main Outcome Measures.</h3> —The percentage of children with a usual source of routine care; the timeliness of visits for routine care; the usual source where routine care is received; and the continuity between sources of care. <h3>Results.</h3> —Poor children with Medicaid coverage were more likely than those without Medicaid to have a usual source of routine care (91% vs 78%,<i>P</i>&lt;.001) and to receive routine care within an appropriate time interval (84% vs 69%,<i>P</i>&lt;.001). However, poor children with Medicaid were less likely than children living above the poverty line to receive routine care in physicians' offices (56% vs 82%,<i>P</i>&lt;.001) and more likely to lack continuity between usual sources of routine and sick care (18% vs 6%,<i>P</i>&lt;.001). Children receiving routine care at community clinics compared with children receiving care at physicians' offices were more likely to receive sick care at a different location than where they receive routine care (40% vs 4%,<i>P</i>&lt;.001) and also more likely to identify an emergency department as their usual source of sick care (9% vs 2%,<i>P</i>&lt;.001). <h3>Conclusions.</h3> —While Medicaid does improve access to care for poor children, it does not ensure them access to the same locations and continuity of care as that available to other children. Recent changes in the Medicaid program may address some of these inequities, but others are likely to remain. (<i>JAMA</i>. 1992;267:2760-2764)
A Long-Term Study on Indolent Adult T-Cell Leukemia/Lymphoma (ATLL).
Authors: Yumi Takasaki, Kunihiro Tsukasaki, Masako Iwanaga, Yoshitaka Imaizumi, Masayuki Tawara, Tatsuro Joh, Tomoko Kohno, Yasuaki Yamada, Shimeru Kamihira, Schuichi Ikeda, Masao Tomonaga
Journal: Blood (2007)
Control of Synaptic Specificity by Establishing a Relative Preference for Synaptic Partners
Authors: Chundi Xu, Emma Theisen, Ryan Maloney, Jing Peng, Ivan Santiago, Clarence Yapp, Zachary Werkhoven, Elijah Rumbaut, Bryan Shum, Dorota Tarnogorska, Jolanta Borycz, Liming Tan, Maximilien Courgeon, Tessa Griffin, Raina Levin, Ian A. Meinertzhagen, Benjamin de Bivort, Jan Drugowitsch, Matthew Y. Pecot
Journal: Neuron (2020)
Circulation: Clinical Summaries
Journal: Circulation (2011)

Implantable cardioverter-defibrillators represent a potentially lifesaving therapy for patients at high risk of sudden cardiac death.In general, the procedure is safe, but complications can and do occur, even among the most experienced implanters.The present study examined data from the National Cardiovascular Data Registry (NCDR) ICD Registry, which has prospectively gathered data on patients undergoing ICD implantation since 2006.The rates of in-hospital complication and mortality were studied in patients from 268 701 hospitalizations at 1300 hospitals.Clinical variables available to the clinician before the procedure were then used to derive a model identifying factors associated with adverse events.This information was used to create a simple risk score to identify patients at high and low risk of adverse events.Patients with low risk scores may not require the level of care usually provided to patients undergoing ICD implantation.Conversely, among patients with high risk scores, the timing of ICD implantation may warrant reevaluation.Practically, the model will be a valuable tool in prospectively assessing whether patients should be admitted to the hospital or remain as outpatients.See p 2069.
The Prevention of Blindness.
Journal: JAMA (1930)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal